Technical Analysis for IGMS - IGM Biosciences, Inc.

Grade Last Price % Change Price Change
grade B 18.58 -1.95% -0.37
IGMS closed down 1.95 percent on Wednesday, October 16, 2019, on 43 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical IGMS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 1.03%
New 52 Week Closing Low Bearish 7.71%
Shooting Star Candlestick Bearish 7.71%
Doji - Bearish? Reversal 7.71%
Down 3 Days in a Row Weakness 7.71%
Down 4 Days in a Row Weakness 7.71%
New 52 Week Closing Low Bearish 6.60%
Hot IPO Pullback Bullish Swing Setup 6.60%
Spinning Top Other 6.60%

Older signals for IGMS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
IGMS Chart by TradingView
Basic chart:
Profile
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Biotechnology Manufacturing Cancer Medical Specialties Immunology Treatment Of Cancer Antibodies Glycoproteins Protein Engineering Biochemistry
Is IGMS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 14 Bernstein sees 19% upside in Amgen in premarket analyst action
Oct 12 Stocks To Watch: Q3 Earnings Blastoff
Oct 2 IGM Biosciences Initiates First-in-Human Phase 1 Clinical Trial of IGM-2323 for the Treatment of Relapsed/Refractory B Cell Non-Hodgkin’s Lymphoma
Oct 1 The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 22 The Week Ahead In Biotech: Spotlight On ESMO Conference
Sep 20 IGM Biosciences closes $200M IPO
Sep 20 IGM Biosciences Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 18 IGM Biosciences Opens Above IPO Price
Sep 18 The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts
See more IGMS news...
Indicators
Indicator Value
52 Week High 24.57
52 Week Low 16.1
Average Volume 136,350
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 18.669
10-Day Moving Average 18.083
Average True Range 2.017
ADX 0.0
+DI 6.875
-DI 15.3204
Chandelier Exit (Long, 3 ATRs ) 18.519
Chandelier Exit (Short, 3 ATRs ) 22.151
Upper Bollinger Band 21.2057
Lower Bollinger Band 16.1323
Percent B (%b) 0.48
BandWidth 27.175532
MACD Line -0.4707
MACD Signal Line -0.4317
MACD Histogram -0.039
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.64
Resistance 3 (R3) 20.74 20.15 20.29
Resistance 2 (R2) 20.15 19.63 20.10 20.18
Resistance 1 (R1) 19.37 19.31 19.08 19.27 20.06
Pivot Point 18.78 18.78 18.64 18.73 18.78
Support 1 (S1) 18.00 18.26 17.71 17.90 17.10
Support 2 (S2) 17.41 17.94 17.36 16.98
Support 3 (S3) 16.63 17.41 16.87
Support 4 (S4) 16.53